Nerium real results for Skin Problems ♂ ♀

NeriumAD is responsible for rectifying a host of various skin calamities...
Many have been researched and proven.

( Cold Sores, Sun Burns, Deep lines, Fine lines, wrinkles, Age Spots and Hyper-pigmentation ) 

While many are just now being discovered
by the happy users who have seen dramatic and lasting results.

It has also greatly approved the occurrence and appearance of:
Psoriasis, Think Skin, Sagging Skin, Itching Skin, Broken Capillaries
Skin Tags, Flaking Skin, Rough Skin, Scared Skin

Clear medical testing has been done, which accurately shows the data of the clear and visible improvements made to skin by using NeriumAD. NeriumAD is all natural and is NOT a pharmaceutical!

Cold Sore (HSV-1) Study
ST&T initiated a pilot study on human subjects that provided for testing a topical application for
 Cold Sores (HSV-1) utilizing the Nerium SkinCare topical formulation Nerium CS™.
ST&T initiated this pilot study to test the safety and efficacy of the Nerium natural topical
oleander-based antiseptic solution, Nerium CS™, to help promote and speed the healing, reduce
symptoms, and/or to mitigate and reduce pain and the spreading of skin irruptions or wounds to
mouth areas [lip lesions, pimples, blemishes, fever blisters, or active cold sore(s)].
Study Aim/Purpose:
The specific aim of this study was to evaluate the safety and efficacy of the natural Nerium topical
 oleander-based antiseptic solution, Nerium CS™, in volunteers with lip lesions, pimples, blemishes,
 fever blisters, or active cold sore(s). Subjects enrolled were all healthy, with no significant medical
history. All had lip lesions, pimples, blemishes, fever blisters, active cold sore(s) thought to be
related to the Herpes Simplex Virus type 1 [HSV-1] (in lab cultures/tests of volunteers, 80% showed
a positive results for HSV-1 and there were 20% who had sores/lesions related to another underlying
It is estimated that recurrent HSV -1 (cold sores of the mouth area) alone affects approximately 20-40%
 (some figures suggest as high as 80%) of the adult population in the United States. The frequency of
the disease among affected individuals varies from rare episodes to 12 or more recurrences per year.
Although there are a variety of intravenous, oral and topical antiviral drug agents tested in clinical
 research settings which have shown efficacy against herpes lesions, there is a need for over-the-counter
 natural antiseptic products with proven efficacy, to help lessen and/or mitigate the symptoms.
Background-Viral Related Skin Eruptions/Vesicles:
Upon contact with the body, HSV-1 penetrates susceptible cells and begins to replicate itself with
cell nuclei, destroying host cells. Clinically, there are five stages of this type of skin infection:
Prodromal Stage: a generalized precursor of herpes infection becomes evident about 6 to 48
hours before a cold sore is visible, subject may feel tingling, burning, itching, numbness, tenderness,
or pain in the affected area, even symptoms consisting of mild malasia, fever and localized
lymphadenopathy, which can occur with HSV-1. The infection then proceeds into a localized skin reaction.
Erythema Stage: an erythematous reaction, or localized redness without induration.
Papular Stage: begins with induration, or hardening of the skin.
Vesicle Stage: The vesicular stage begins with destruction of host cells causing painful eruption of
Ulcer Stage: The blisters ulcerate and form a crust, drying out and healing rapidly. When the crust falls
 off, the virus is no longer transmissible, or contagious.
The mean duration of recurrence is 7-12 days, and sometimes up to 2 weeks or more. The viral 
particles persist in its latent form, without symptoms, in the neural ganglia until recurrence. Viral 
replication usually occurs at the same site, triggered by a variety of different factors, such as 
sunlight, physical, environmental or emotional stress and cell destruction with subsequent vesicle 
formation begins again. It is suggested that viral shedding begins prior to vesicle formation.
Clinical Summary:
In the study of this natural Nerium oleander-based topical antiseptic solution, Nerium CS™, it
was found that its effectiveness help promote and speed the healing, reduce symptoms, and/or
to mitigate and reduce pain and the spreading of skin irruptions or wounds to outside mouth areas
 in form of lip lesions, pimples, blemishes, fever blisters, or active cold sore(s) / HSV-1. The Nerium
topical solution was faster than or equal to traditional drug therapies, though it was found that its
greatest success on inhibiting and/or clearing of vesicles was if it is applied early, before or at the
early onset of the outbreak.
Participant blood samples were done at visit day 1 (screening) and at the study conclusion (their
 last visit). A comprehensive blood chemistry panel was run to test for oleandrin absorption and
accumulation in the blood. From results of the blood test, there were no adverse reactions noted,
 blood analysis showed all subjects within normal ranges, and that there was no detectable CG’s
 in the blood.  
The subjects were enrolled for the natural Nerium CS™ treatment duration of 10-26 days depending
 on the severity of cold sore and time they took to heal. On average, subjects where the Nerium
 antiseptic solution was applied at stage 1-2 (Prodromal or Erythema), rarely progressed to other
 stages and vesicles cleared within two days. Subjects who were seen in stage 3-4 (Papular or
Vesicle) before applying the antiseptic solution experienced a healing time of two to four days on
 average, other subjects presenting at stages 3, 4, or 5 (Papular, Vesicle, or Ulcer) had varying
results from 3-5 days on average and up to 10 days or more (likely dependent upon the infection
 or viral load, environmental considerations, i.e. stressors, diet, sun [UV radiation] exposure,
etc.). Solution effectiveness was apparent, (faster than or equal to traditional drug therapies),
 though it had greatest success on inhibiting and/or clearing vesicles if applied before or at the
 early onset of the outbreak.
Reference Sources:
(3) S1 Thomas, Clayton L., Editor (1997). Taber’s Cyclopedic Medical Dictionary. F.A. Davis
Company, Philadelphia, PA [18th Edition].
S2 Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby’s Diagnostic and Laboratory
Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO.
S3 American Medical Association (2002). Current Procedural Terminology, cpt 2002, Standard Edition.